Aristippos Gennadios, President Softgel & Oral Technology at Catalent, Inc. (CTLT), sold 45,256 shares at $52.55 ($2.4M) on 2019-11-25, disclosed to the SEC on 2019-11-27.
Open-market sale of $2.4M CTLT by President Softgel & Oral Technology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CTLT | SELL | 2023-08-25 | $18K | — | Filing → |
| CTLT | SELL | 2023-08-03 | $13K | — | Filing → |
| CTLT | SELL | 2022-08-26 | $339K | — | Filing → |